BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/5/e060342.full |
| _version_ | 1828199442978701312 |
|---|---|
| author | Zeynep Eroglu Joe Ensor Meenakshi Malhotra Paul Billings Angel Rodriguez Alexey Aleshin Ling Gao Sarah Sawyer Pashtoon Murtaza Kasi Sascha Ellers George Ansstas Michael Krainock Sakti Chakrabarti Andrew Poklepovic Minu Maninder |
| author_facet | Zeynep Eroglu Joe Ensor Meenakshi Malhotra Paul Billings Angel Rodriguez Alexey Aleshin Ling Gao Sarah Sawyer Pashtoon Murtaza Kasi Sascha Ellers George Ansstas Michael Krainock Sakti Chakrabarti Andrew Poklepovic Minu Maninder |
| author_sort | Zeynep Eroglu |
| collection | DOAJ |
| first_indexed | 2024-04-12T10:55:11Z |
| format | Article |
| id | doaj.art-1710b670c7d04923bb1d5cd95028e149 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-12T10:55:11Z |
| publishDate | 2022-05-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-1710b670c7d04923bb1d5cd95028e1492022-12-22T03:36:06ZengBMJ Publishing GroupBMJ Open2044-60552022-05-0112510.1136/bmjopen-2021-060342BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumoursZeynep Eroglu0Joe Ensor1Meenakshi Malhotra2Paul Billings3Angel Rodriguez4Alexey Aleshin5Ling Gao6Sarah Sawyer7Pashtoon Murtaza Kasi8Sascha Ellers9George Ansstas10Michael Krainock11Sakti Chakrabarti12Andrew Poklepovic13Minu Maninder14Departments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Center Inc, Tampa, Florida, USAHouston Methodist Research Institute, Houston, Texas, USAScientific Affairs, Natera Inc, San Carlos, California, USANatera Inc, San Carlos, California, USANatera Inc, San Carlos, California, USANatera Inc, San Carlos, California, USADepartment of Cardiology, Chengdu University of Traditional Chinese Medicine Affiliated Fifth People`s Hospital, Chengdu, Sichuan, ChinaNatera Inc, San Carlos, California, USADepartment of Oncology/Hematology, Division of Internal Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USANatera Inc, San Carlos, California, USA1Washington University in Saint Louis, St. Louis, MO, USANatera Inc, San Carlos, California, USAMedical College of Wisconsin, Milwaukee, Wisconsin, USAVCU Health System Massey Cancer Center, Richmond, Virginia, USANatera Inc, Austin, Texas, USAhttps://bmjopen.bmj.com/content/12/5/e060342.full |
| spellingShingle | Zeynep Eroglu Joe Ensor Meenakshi Malhotra Paul Billings Angel Rodriguez Alexey Aleshin Ling Gao Sarah Sawyer Pashtoon Murtaza Kasi Sascha Ellers George Ansstas Michael Krainock Sakti Chakrabarti Andrew Poklepovic Minu Maninder BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours BMJ Open |
| title | BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours |
| title_full | BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours |
| title_fullStr | BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours |
| title_full_unstemmed | BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours |
| title_short | BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours |
| title_sort | bespoke io protocol a multicentre prospective observational study evaluating the utility of ctdna in guiding immunotherapy in patients with advanced solid tumours |
| url | https://bmjopen.bmj.com/content/12/5/e060342.full |
| work_keys_str_mv | AT zeyneperoglu bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT joeensor bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT meenakshimalhotra bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT paulbillings bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT angelrodriguez bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT alexeyaleshin bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT linggao bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT sarahsawyer bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT pashtoonmurtazakasi bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT saschaellers bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT georgeansstas bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT michaelkrainock bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT saktichakrabarti bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT andrewpoklepovic bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours AT minumaninder bespokeioprotocolamulticentreprospectiveobservationalstudyevaluatingtheutilityofctdnainguidingimmunotherapyinpatientswithadvancedsolidtumours |